网站主页 >> CAS数据库列表 >> SLLK, Control Peptide for TSP1 Inhibitor(TFA)
SLLK, Control Peptide for TSP1 Inhibitor(TFA)
|
|
|
- CAS号:
- 英文名:
- SLLK, Control Peptide for TSP1 Inhibitor(TFA)
- 英文别名:
- SLLK, Control Peptide for TSP1 Inhibitor(TFA)
- 中文名:
- SLLK, Control Peptide for TSP1 Inhibitor(TFA)
- 中文别名:
- CBNumber:
- CB54845059
- 分子式:
- C??H??F?N?O?
- 分子量:
- 0
- MOL File:
- Mol file
|
|
|
SLLK, Control Peptide for TSP1 Inhibitor(TFA)化学性质
-
序列:
-
H-Ser-Leu-Leu-Lys-NH2
-
|
SLLK, Control Peptide for TSP1 Inhibitor(TFA)性质、用途与生产工艺
SLLK, Control Peptide for TSP1 Inhibitor (TFA) 是血小板反应蛋白抑制剂 (TSP-1) LSKL 的对照肽。
Akita mice treated with 30 mg/kg LSKL have significantly increased nephrin expression, greater than twofold, compared with renal lysates from either saline controls or SLLK-treated mice.TGF-β1 is significantly lower (0.10±0.01 pg/mL) in the plasma of mice receiving LSKL compared with that in plasma of mice receiving SLLK control peptide at day 42 (0.20±0.02 pg/mL; P=0.0001). MRNA expression is assessed in the suprarenal aortic lysates obtained from mice receiving SLLK and LSKL peptides.
多肽
SLLK是血小板反应蛋白抑制剂(TSP-1)?LSKL的对照肽，是一条由四个氨基酸组成的短肽，其中多肽的C端被酰胺键封闭，具有较好的稳定性。
参考质量标准
外观:白色粉末
纯度(HPLC) ≥98.0%
醋酸根含量≤12.0%
水分含量≤8.0%
肽含量≥80.0%
内毒素≤50EU/mg
氨基酸组成分析≤±10%
SLLK, Control Peptide for TSP1 Inhibitor(TFA)
上下游产品信息
上游原料
下游产品
SLLK, Control Peptide for TSP1 Inhibitor(TFA) 试剂级价格
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2024/04/30 | HY-P0301A | SLLK, Control Peptide for TSP1 Inhibitor(TFA)
SLLK, Control Peptide for TSP1 Inhibitor(TFA) | | 1mg | 900元 |
| 2024/04/30 | HY-P0301A | SLLK, Control Peptide for TSP1 Inhibitor(TFA)
SLLK, Control Peptide for TSP1 Inhibitor(TFA) | | 5mg | 1890元 |
SLLK, Control Peptide for TSP1 Inhibitor(TFA)
生产厂家
SLLK, Control Peptide for TSP1 Inhibitor(TFA) 相关搜索:
- SLLK, Control Peptide for TSP1 Inhibitor(TFA)